• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

FDA Fast Tracks INX-315 for Tough-to-Treat Ovarian Cancer

by MM360 Staff | Apr 29, 2025 | Uncategorized

Source: CureToday articles INX-315, a CDK2 inhibitor, received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian cancer. Read More

SIRT With 90Y Resin Microspheres Provides Benefit in GIST Liver Metastases

by MM360 Staff | Apr 29, 2025 | Uncategorized

Source: CureToday articles SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver metastases resistant to TKI therapy. Read More

Alternating Glivec and Stivarga Doesn’t Improve Advanced GIST Outcomes

by MM360 Staff | Apr 28, 2025 | Uncategorized

Source: CureToday articles Alternating between Glivec and Stivarga therapy didn’t impact survival outcomes; it led to more toxicity and discontinuations in patients with GIST. Read More

Breast MRI Offers Sensitive Imaging for High-Risk and Diagnosed Patients

by MM360 Staff | Apr 28, 2025 | Uncategorized

Source: CureToday articles Breast MRI helps doctors detect disease in newly diagnosed and high-risk patients without replacing mammograms, according to an expert. Read More

Neoadjuvant Mitomycin C Shows Favorable Safety in Bladder Cancer

by MM360 Staff | Apr 28, 2025 | Uncategorized

Source: CureToday articles Among patients with non–muscle-invasive bladder cancer, neoadjuvant mitomycin demonstrated favorable safety. Read More

How Mammogram Reminders Can Be More Thoughtful Following Breast Cancer

by MM360 Staff | Apr 28, 2025 | Uncategorized

Source: CureToday articles I reflect on how a generic mammogram reminder overlooked my experience as a breast cancer survivor and how thoughtful messaging could make a difference. Read More
« Older Entries
Next Entries »

Recent Content

  • Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from Clinical Trials
  • Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study
  • Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma
  • Subcutaneous Darzalex Faspro Extends PFS in Smoldering Myeloma
  • A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
  • Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma
  • Multiple Myeloma: Key Insights on Diagnosis and Evolving Treatment Strategies
  • Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation
  • Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab
  • Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT